We report, for the first time, infectious complications after CD30 CAR T-cell treatment for patients with Hodgkin lymphoma and peripheral T-cell lymphoma. This evidence concerns the gene TNFRSF8 and peripheral T-cell lymphoma, not otherwise specified.